Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have earned an average recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $21.80.

SBRA has been the topic of several analyst reports. Citigroup lifted their price target on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. Jefferies Financial Group restated a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Wall Street Zen lowered Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Finally, Scotiabank boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several institutional investors and hedge funds have recently made changes to their positions in SBRA. Hsbc Holdings PLC increased its stake in shares of Sabra Healthcare REIT by 19.7% in the fourth quarter. Hsbc Holdings PLC now owns 514,409 shares of the real estate investment trust’s stock worth $9,738,000 after buying an additional 84,784 shares during the last quarter. Beaird Harris Wealth Management LLC acquired a new stake in Sabra Healthcare REIT in the fourth quarter valued at $114,000. Corient Private Wealth LLC bought a new position in Sabra Healthcare REIT during the 4th quarter valued at $266,000. Mercer Global Advisors Inc. ADV grew its holdings in Sabra Healthcare REIT by 14.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 66,869 shares of the real estate investment trust’s stock worth $1,267,000 after acquiring an additional 8,411 shares in the last quarter. Finally, EP Wealth Advisors LLC bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth about $300,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Up 2.0%

NASDAQ SBRA opened at $20.42 on Monday. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT has a fifty-two week low of $15.75 and a fifty-two week high of $21.07. The business has a 50 day moving average price of $19.48 and a two-hundred day moving average price of $18.96. The stock has a market cap of $5.15 billion, a PE ratio of 31.91, a P/E/G ratio of 1.64 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. During the same quarter in the prior year, the business earned $0.36 EPS. The company’s revenue for the quarter was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts predict that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 5.9%. Sabra Healthcare REIT’s payout ratio is currently 187.50%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.